[A case of superior vena cava syndrome treated with combination radiation and CRE (CBDCA and VP-16) therapy].
Carboplatin and etoposide were reported to be excellent radiation sensitizers. We encountered a patient with SVC syndrome due to lung cancer who was successfully treated by combination carboplatin, etoposide and hyperfractionation radiotherapy. A 72-year-old man was admitted to our hospital because of remarkable face edema. Computed tomography revealed a huge lung tumor and compressed SVC due to tumor growth. Acute tumor regression was essential for this case. We performed combination chemotherapy and radiation. The regime consisted of CBDCA 300 mg (day 1 1 hr drip infusion) and etoposide 50 mg/day for 21 days by oral administration. Two daily fractionations of 1.4 Gy were delivered 5 days-a-week, with a 4 h interval between fractions (total dose 49.8 Gy). Complete response of huge tumor was attained in this case. The major side effect associated with the therapy was myelosuppression. The patient's quality of life has been remarkably improved with this therapy.
Kato
M
M
Dept. of Radiology, Osaka JR Hospital.
Akimoto
S
S
Akimoto
K
K
Komatsu
T
T
Nakaoka
Y
Y
Kinoshita
M
M
Minami
K
K
Sekikawa
S
S
Kasahara
T
T
Shimizu
T
T
Kizu
O
O
Maeda
T
T
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016190:Carboplatin / Q000008:administration & dosage; D002294:Carcinoma, Squamous Cell / Q000150:complications / Q000188:drug therapy / Q000532:radiotherapy; D003131:Combined Modality Therapy; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications / Q000188:drug therapy / Q000532:radiotherapy; D008297:Male; D011879:Radiotherapy Dosage; D013479:Superior Vena Cava Syndrome / Q000188:drug therapy* / Q000209:etiology / Q000532:radiotherapy*
D005047:Etoposide; D016190:Carboplatin